Cargando…
Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors that condition patient preferences on its use. Inclu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689494/ https://www.ncbi.nlm.nih.gov/pubmed/36421328 http://dx.doi.org/10.3390/curroncol29110675 |
_version_ | 1784836549165187072 |
---|---|
author | Ribera, Paula Soriano, Sandra Climent, Carla Vilà, Laia Macias, Ismael Fernández-Morales, Luis Antonio Giner, Julia Gallardo, Enrique Palmer, Miquel Angel Segui Pericay, Carles |
author_facet | Ribera, Paula Soriano, Sandra Climent, Carla Vilà, Laia Macias, Ismael Fernández-Morales, Luis Antonio Giner, Julia Gallardo, Enrique Palmer, Miquel Angel Segui Pericay, Carles |
author_sort | Ribera, Paula |
collection | PubMed |
description | Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors that condition patient preferences on its use. Included patients had a confirmed cancer diagnosis and were contacted by telephone between 13 March and 30 April 2020, in the Medical Oncology Service of Hospital Parc Taulí, Sabadell. A 12-question survey was presented to them between 4 February and 19 April 2021. Statistical analysis was carried out using chi-square and multivariable logistic regression tests. Six hundred forty-six patients were included; 487 responded to the survey. The median age was 68 years (27–90), 55.2% were female. Most patients had a surveillance visit (65.3%) and were diagnosed with colorectal or breast cancer (43% and 26.5%, respectively); 91.8% of patients were satisfied, and 60% would accept the use of telemedicine beyond the pandemic. Patients aged more than 50 years (OR 0.40; 95% CI, 0.19–0.81; p = 0.01) and diagnosed with breast cancer (OR 0.45; 95% CI, 0.26–0.69; p < 0.001) were less predisposed to adopt telehealth in the future. Patients agreed to be informed via telehealth of scan or lab results (62% and 84%, respectively) but not of new oral or endovenous treatments (52% and 33.5%, respectively). Additionally, 75% of patients had a medium or low-null technologic ability, and 51.3% would only use the telephone or video call to contact health professionals. However, differences were found according to age groups (p < 0.0001). In total, patients surveyed were satisfied with telemedicine and believed telehealth could have a role following the COVID-19 pandemic. Moreover, our results remark on the importance of individualizing the use of telehealth, showing relevant data on patient preferences and digital literacy. |
format | Online Article Text |
id | pubmed-9689494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96894942022-11-25 Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic Ribera, Paula Soriano, Sandra Climent, Carla Vilà, Laia Macias, Ismael Fernández-Morales, Luis Antonio Giner, Julia Gallardo, Enrique Palmer, Miquel Angel Segui Pericay, Carles Curr Oncol Article Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors that condition patient preferences on its use. Included patients had a confirmed cancer diagnosis and were contacted by telephone between 13 March and 30 April 2020, in the Medical Oncology Service of Hospital Parc Taulí, Sabadell. A 12-question survey was presented to them between 4 February and 19 April 2021. Statistical analysis was carried out using chi-square and multivariable logistic regression tests. Six hundred forty-six patients were included; 487 responded to the survey. The median age was 68 years (27–90), 55.2% were female. Most patients had a surveillance visit (65.3%) and were diagnosed with colorectal or breast cancer (43% and 26.5%, respectively); 91.8% of patients were satisfied, and 60% would accept the use of telemedicine beyond the pandemic. Patients aged more than 50 years (OR 0.40; 95% CI, 0.19–0.81; p = 0.01) and diagnosed with breast cancer (OR 0.45; 95% CI, 0.26–0.69; p < 0.001) were less predisposed to adopt telehealth in the future. Patients agreed to be informed via telehealth of scan or lab results (62% and 84%, respectively) but not of new oral or endovenous treatments (52% and 33.5%, respectively). Additionally, 75% of patients had a medium or low-null technologic ability, and 51.3% would only use the telephone or video call to contact health professionals. However, differences were found according to age groups (p < 0.0001). In total, patients surveyed were satisfied with telemedicine and believed telehealth could have a role following the COVID-19 pandemic. Moreover, our results remark on the importance of individualizing the use of telehealth, showing relevant data on patient preferences and digital literacy. MDPI 2022-11-11 /pmc/articles/PMC9689494/ /pubmed/36421328 http://dx.doi.org/10.3390/curroncol29110675 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ribera, Paula Soriano, Sandra Climent, Carla Vilà, Laia Macias, Ismael Fernández-Morales, Luis Antonio Giner, Julia Gallardo, Enrique Palmer, Miquel Angel Segui Pericay, Carles Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic |
title | Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic |
title_full | Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic |
title_fullStr | Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic |
title_full_unstemmed | Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic |
title_short | Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic |
title_sort | teleoncology: a solution for everyone? a single-center experience with telemedicine during the coronavirus disease 2019 (covid-19) pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689494/ https://www.ncbi.nlm.nih.gov/pubmed/36421328 http://dx.doi.org/10.3390/curroncol29110675 |
work_keys_str_mv | AT riberapaula teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT sorianosandra teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT climentcarla teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT vilalaia teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT maciasismael teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT fernandezmoralesluisantonio teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT ginerjulia teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT gallardoenrique teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT palmermiquelangelsegui teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic AT pericaycarles teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic |